Atlas Trials

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

Clinical trial NCT03363178 · UNKNOWN

Trial details

NCT number
NCT03363178
Sponsor
Green Cross Corporation
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2017-12-14
Primary completion
2018-03-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.